Adequacy of Inclusion of Older Adults in NIH‐Funded Phase III Clinical Trials
Authors:
- 29 January 2019
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 67 (2) , 218-222
Abstract
In the United States, the population aged 65 and older is rapidly growing, and this group uses more healthcare resources and has unique healthcare needs that do not exist in younger populations. However, it was reported that older adults are excluded or underrepresented in clinical trials for several diseases. We examined phase III clinical trials funded by the National Institutes of Health found in www.clinicaltrials.gov from 1965 to 2015 that addressed top causes for hospitalization and/or disability‐adjusted life years in older adults: congestive heart failure (n = 45), cardiac dysrhythmias (n = 24), coronary atherosclerosis (n = 106), heart attack (n = 76), stroke (n = 113), chronic obstructive pulmonary disease (n = 14), pneumonia (n = 48), lung cancer (n = 117), prostate cancer (n = 65), and osteoarthritis (n = 15). We then analyzed the representation of older adults in these studies. We found that 33% of studies had arbitrary upper age limits, and 67% of studies reported mean and/or median ages that skewed younger than expected for the disease or condition of interest. Beyond explicit exclusion by age, older adults were often implicitly excluded based on various comorbid conditions such as polypharmacy/concomitant medication (37%) or cardiac issues (30%). We conclude that outcomes of these trials may not be fully generalizable to the general population of older adults. J Am Geriatr Soc 67:218–222, 2019.Keywords
This publication has 10 references indexed in Scilit:
- Inclusion Across the LifespanJAMA, 2018
- Exclusion of Elderly People from Randomized Clinical Trials of Drugs for Ischemic Heart DiseaseJournal of the American Geriatrics Society, 2017
- Publication of Trials Funded by the National Heart, Lung, and Blood InstituteNew England Journal of Medicine, 2013
- Prevalence of Multiple Chronic Conditions Among Medicare Beneficiaries, United States, 2010Preventing Chronic Disease, 2013
- Exclusion of Older Adults from Ongoing Clinical Trials About Type 2 Diabetes MellitusJournal of the American Geriatrics Society, 2013
- Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?Journal of Thoracic Oncology, 2013
- Informing Evidence-Based Decision-Making for Patients with Comorbidity: Availability of Necessary Information in Clinical Trials for Chronic DiseasesPLOS ONE, 2012
- The elderly were under-represented in osteoarthritis clinical trialsJournal of Clinical Epidemiology, 2009
- Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive studyBMJ, 2000
- The Exclusion of the Elderly and Women From Clinical Trials in Acute Myocardial InfarctionJAMA, 1992